PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2009. Start Trial.
Date Value
November 13, 2026 7.630
November 12, 2026 7.686
November 11, 2026 8.002
November 10, 2026 8.032
November 09, 2026 8.289
November 06, 2026 7.966
November 05, 2026 7.834
November 04, 2026 8.188
November 03, 2026 8.247
November 02, 2026 8.158
October 30, 2026 8.476
October 29, 2026 8.391
October 28, 2026 8.510
October 27, 2026 6.635
October 26, 2026 6.638
October 23, 2026 6.505
October 22, 2026 5.942
October 21, 2026 5.878
October 20, 2026 5.804
October 19, 2026 5.719
October 16, 2026 5.496
October 15, 2026 5.618
October 14, 2026 5.480
October 13, 2026 5.432
October 12, 2026 5.551
Date Value
October 09, 2026 5.506
October 08, 2026 5.355
October 07, 2026 5.444
October 06, 2026 5.615
October 05, 2026 5.716
October 02, 2026 5.162
October 01, 2026 5.132
September 30, 2026 5.299
September 29, 2026 5.492
September 28, 2026 5.460
September 25, 2026 5.453
September 24, 2026 5.378
September 23, 2026 5.365
September 22, 2026 5.438
September 21, 2026 5.356
September 18, 2026 5.364
September 17, 2026 5.332
September 16, 2026 5.311
September 15, 2026 5.273
September 14, 2026 5.041
September 11, 2026 5.013
September 10, 2026 4.976
September 09, 2026 5.101
September 08, 2026 5.177
September 04, 2026 5.188

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
AbbVie, Inc. 7.923
Incyte Corp. 4.141
Ascendis Pharma A/S 12.96
Zealand Pharma A/S 3.478
Bavarian Nordic A/S 2.746

PS Ratio Related Metrics